PMID- 25103256 OWN - NLM STAT- MEDLINE DCOM- 20150703 LR - 20211021 IS - 1582-4934 (Electronic) IS - 1582-1838 (Print) IS - 1582-1838 (Linking) VI - 18 IP - 11 DP - 2014 Nov TI - Shear flow affects selective monocyte recruitment into MCP-1-loaded scaffolds. PG - 2176-88 LID - 10.1111/jcmm.12330 [doi] AB - Novel cardiovascular replacements are being developed by using degradable synthetic scaffolds, which function as a temporary guide to induce neotissue formation directly in situ. Priming of such scaffolds with fast-releasing monocyte chemoattractant protein-1 (MCP-1) was shown to improve the formation of functional neoarteries in rats. However, the underlying mechanism has not been clarified. Therefore, the goal of this study was to investigate the effect of a burst-release of MCP-1 from a synthetic scaffold on the local recruitment of circulating leucocytes under haemodynamic conditions. Herein, we hypothesized that MCP-1 initiates a desired healing cascade by recruiting favourable monocyte subpopulations into the implanted scaffold. Electrospun poly(epsilon-caprolactone) scaffolds were loaded with fibrin gel containing various doses of MCP-1 and exposed to a suspension of human peripheral blood mononuclear cells in static or dynamic conditions. In standard migration assay, a dose-dependent migration of specific CD14(+) monocyte subsets was observed, as measured by flow cytometry. In conditions of pulsatile flow, on the other hand, a marked increase in immediate monocyte recruitment was observed, but without evident selectivity in monocyte subsets. This suggests that the selectivity was dependent on the release kinetics of the MCP-1, as it was overruled by the effect of shear stress after the initial burst-release. Furthermore, these findings demonstrate that local recruitment of specific MCP-1-responsive monocytes is not the fundamental principle behind the improved neotissue formation observed in long-term in vivo studies, and mobilization of MCP-1-responsive cells from the bone marrow into the bloodstream is suggested to play a predominant role in vivo. CI - (c) 2014 The Authors. Journal of Cellular and Molecular Medicine published by John Wiley & Sons Ltd and Foundation for Cellular and Molecular Medicine. FAU - Smits, Anthal I P M AU - Smits AI AD - Soft Tissue Biomechanics and Tissue Engineering, Department of Biomedical Engineering, Eindhoven University of Technology, Eindhoven, The Netherlands. FAU - Ballotta, Virginia AU - Ballotta V FAU - Driessen-Mol, Anita AU - Driessen-Mol A FAU - Bouten, Carlijn V C AU - Bouten CV FAU - Baaijens, Frank P T AU - Baaijens FP LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't DEP - 20140808 PL - England TA - J Cell Mol Med JT - Journal of cellular and molecular medicine JID - 101083777 RN - 0 (CCL2 protein, human) RN - 0 (Chemokine CCL2) RN - 0 (Polyesters) RN - 24980-41-4 (polycaprolactone) SB - IM MH - Absorbable Implants MH - Animals MH - Cell Count MH - Cells, Cultured MH - Chemokine CCL2/chemistry/*metabolism MH - Coronary Vessels/cytology/*growth & development/metabolism MH - Humans MH - Leukocytes, Mononuclear/*cytology/metabolism MH - Male MH - Polyesters/chemistry MH - Rats MH - *Tissue Scaffolds PMC - PMC4224552 OTO - NOTNLM OT - CCL2 OT - angiogenic monocytes OT - bioactive scaffold OT - cardiovascular OT - chemotaxis OT - haemodynamics OT - immunomodulation OT - in situ tissue engineering OT - peripheral blood mononuclear cells EDAT- 2014/08/12 06:00 MHDA- 2015/07/04 06:00 PMCR- 2014/11/01 CRDT- 2014/08/09 06:00 PHST- 2013/12/10 00:00 [received] PHST- 2014/04/23 00:00 [accepted] PHST- 2014/08/09 06:00 [entrez] PHST- 2014/08/12 06:00 [pubmed] PHST- 2015/07/04 06:00 [medline] PHST- 2014/11/01 00:00 [pmc-release] AID - 10.1111/jcmm.12330 [doi] PST - ppublish SO - J Cell Mol Med. 2014 Nov;18(11):2176-88. doi: 10.1111/jcmm.12330. Epub 2014 Aug 8.